Trial intelligence / Profile preview

Tailored Clopidogrel Therapy in ACS Patients with High Platelet Reactivity

NCT00774475Phase 3Unknown

Sponsor
Università degli Studi di Firenze
Start
Nov 2008
Primary completion
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of clopidogrel in unstable angina, non-ST elevation myocardial infarction (NSTEMI), sponsored by Università degli Studi di Firenze. Status: unknown.

02

Drugs

clopidogrel
03

Conditions

unstable anginanon-ST elevation myocardial infarction (NSTEMI)

Beyond the preview

Go deeper on NCT00774475.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00774475.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call